Results 81 to 90 of about 1,511 (99)

Erratum: Cost elements to be considered in estimates for microcosting studies in peritoneal dialysis (PD) therapy in Latin America. [PDF]

J Bras Nefrol
europepmc   +1 more source

Prevention is less expensive than treatment in chronic kidney disease: a descriptive analysis. [PDF]

J Bras Nefrol
Alcalde PR, Fernandes DE, Kirsztajn GM.
europepmc   +1 more source

Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]

J Bras Nefrol
Mathew GG.
europepmc   +1 more source

Troponin I is an independent marker of cardiovascular mortality risk in chronic kidney disease patients. [PDF]

J Bras Nefrol
Romaniello G, Hayashi SY, Guerra BS, Riella MC, Lindholm B, Marques GL, Nascimento MMD.   +6 more
europepmc   +1 more source

Innovation in daily hemodialysis: high-flux vs. hemodiafiltration. [PDF]

J Bras Nefrol
Silva DRD.
europepmc   +1 more source

Brazilian Dialysis Survey 2023. [PDF]

J Bras Nefrol
Nerbass FB, Lima HDN, Strogoff-de-Matos JP, Zawadzki B, Moura-Neto JA, Lugon JR, Sesso R.   +6 more
europepmc   +1 more source

Clinical and Laboratory Predictors for the Development of Heart Valve Diseases in Chronic Kidney Disease: A Systematic Review. [PDF]

Arq Bras Cardiol
Conceição HMC, Valois ALV, Ramos EMS, Ladeia AM.   +3 more
europepmc   +1 more source

Beyond Atherosclerosis: Mind the Valves in Chronic Kidney Disease. [PDF]

Arq Bras Cardiol
Cabral S.
europepmc   +1 more source

The impact of bone histomorphometry, bone-related biomarkers, and FRAX® on fractures patients with predialysis CKD. [PDF]

J Bras Nefrol
Lopes MFD, Fernandes BJC, Rocha MTAESMD, Costa MLC, Frazão JMMD, Pereira Neto RM.   +5 more
europepmc   +1 more source